BU
TMO icon

BBVA USA’s Thermo Fisher Scientific TMO Stock Holding History

BBVA USA’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$7.03M Sell
12,304
-1,281
-9% -$703K 0.41% 56
2021
Q2 		$6.85M Buy
+13,585
New +$6.41M 0.38% 57

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BBVA USA's TMO Position: Q3 2021 in Review

BBVA USA reduced its Thermo Fisher Scientific (TMO) stake by 9.4% in Q3 2021, selling an estimated $703K and leaving 12,304 shares worth $7.03M. The position accounts for 0.41% of the portfolio, ranked #56.

BBVA USA first reported a position in TMO in Q2 2021 and has held it in 2 quarters since. 2,128 funds tracked by Wall St. Rank hold TMO as of Q3 2021.

  • BBVA USA held 12,304 shares of Thermo Fisher Scientific worth $7.03M as of Q3 2021.
  • BBVA USA sold 1,281 Thermo Fisher Scientific shares in Q3 2021, an estimated $703K.
  • Thermo Fisher Scientific made up 0.41% of BBVA USA's portfolio in Q3 2021, its #56 holding.
  • BBVA USA first reported a position in Thermo Fisher Scientific in Q2 2021 and has held it in 2 quarters since.
  • 2,128 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.